Dr. El Jurdi and her team at the National Institutes of Health (NIH) are seeking adults and children aged 12 and older with myelodysplastic syndrome (MDS) or myelodysplastic/myeloproliferative neoplasm (MDS/MPN) for a clinical research study. This clinical research study is evaluating the safety and effectiveness of an investigational drug, pacritinib. Parental consent is required for minors.
What to Expect
- Screening period: one to four weeks
- Medical history review and physical exam
- Blood tests, including infection screening and pregnancy testing echocardiogram
- Heart tests, including an ECG and echocardiogram
- Bone marrow biopsy, if needed to confirm your diagnosis
If You Qualify
- Take the study drug twice a day by mouth
- Have standard blood tests at regular intervals
- Attend study visits at regular intervals while taking the study drug
- Participate in the study for up to 8 years
Location
The NIH Clinical Center, America's research hospital, is located in Bethesda, Maryland and is accessible by the Metro Red Line (Medical Center stop).
For More Information
NIH Clinical Center Office of Patient Recruitment
833-JOIN-NIH
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Refer to NIH study # 001554-C
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)